Alnylam Pharmaceuticals (ALNY) Earnings (2009 - 2025)
Alnylam Pharmaceuticals (ALNY) earnings from Jun 30, 2009 to Dec 31, 2025. The TTM Alnylam Pharmaceuticals (ALNY) earnings is $314M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Annual Earnings change of Alnylam Pharmaceuticals (ALNY)
| Year | Earnings | Change |
|---|---|---|
| 2025 | $314M | -212.79% |
| 2024 | -$278M | -36.82% |
| 2023 | -$440M | -61.08% |
| 2022 | -$1.13B | +32.64% |
| 2021 | -$853M | -0.64% |
| 2020 | -$858M | -3.14% |
| 2019 | -$886M | +16.37% |
| 2018 | -$762M | +55.13% |
| 2017 | -$491M | +19.69% |
| 2016 | -$410M | +41.38% |
| 2015 | -$290M | -19.51% |
| 2014 | -$360M | +303.93% |
| 2013 | -$89M | -15.84% |
| 2012 | -$106M | +83.89% |
| 2011 | -$58M | +32.50% |
| 2010 | -$44M | -8.57% |
| 2009 | -$48M | +81.30% |
| 2008 | -$26M | N/A |